Stay updated with breaking news from Nasdaq Acrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a research note released on Friday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. A number of other research analysts also recently issued reports on the company. Alliance Global Partners initiated coverage on AcelRx Pharmaceuticals in a research […]
StockNews.com assumed coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a research note issued to investors on Friday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. ACRX has been the topic of a number of other reports. HC Wainwright reaffirmed a buy rating and set a $5.00 target […]
HC Wainwright reissued their buy rating on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a research note released on Thursday, Benzinga reports. They currently have a $5.00 price target on the specialty pharmaceutical company’s stock. Several other research firms have also weighed in on ACRX. Alliance Global Partners assumed coverage on shares of […]
AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, November 8th. Analysts expect the company to announce earnings of ($0.29) per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link. AcelRx Pharmaceuticals (NASDAQ:ACRX – […]
Equities researchers at StockNews.com initiated coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Get Free Report) in a research report issued on Thursday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. ACRX has been the topic of several other research reports. Alliance Global Partners assumed coverage on AcelRx Pharmaceuticals in a […]